Given the central role of RyRs in calcium signaling, and the involvement of these proteins in pathways relevant to tumor progression, we speculate that the expression and activity of RyRs such as RYR1 may have an effect on the response of HNC patients to treatments. Here, RYR1 is linked to neoplasm.